Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Express Scripts
McKinsey
Medtronic
Merck

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for L-Cysteine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug L-Cysteine: Patents, clinical trial progress, indications

L-Cysteine is an investigational drug.

There have been 16 clinical trials for L-Cysteine. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Schizophrenia, Hearing Loss, and Brain Injuries. The leading clinical trial sponsors are National Cancer Institute (NCI), Peking University People's Hospital, and Ain Shams University.

There are one hundred and eighty-five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for L-Cysteine
TitleSponsorPhase
Effect of N-Acetyl Cysteine (NAC) on the Oral MicrobiomeWake Forest University Health SciencesPhase 2
Risk Stratification-directed NAC for Prevention of Poor Hematopoietic ReconstitutionPeking University People's HospitalPhase 3
Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationPeking University People's HospitalPhase 2

See all L-Cysteine clinical trials

Clinical Trial Summary for L-Cysteine

Top disease conditions for L-Cysteine
Top clinical trial sponsors for L-Cysteine

See all L-Cysteine clinical trials

US Patents for L-Cysteine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Cysteine   See Pricing Benzoylphenyl pyridinylthiazolidine compounds as platelet activating antagonists Abbott Laboratories (Abbott Park, IL)   See Pricing
L-Cysteine   See Pricing Methods of treating Parkinson's disease using melanin   See Pricing
L-Cysteine   See Pricing Inhibitors of farnesyl protein transferase Merck & Co., Inc. (Rahway, NJ)   See Pricing
L-Cysteine   See Pricing Diamino acid derivatives as antihypertensives Schering Corporation (Kenilworth, NJ)   See Pricing
L-Cysteine   See Pricing Peptide analog type-B CCK receptor ligands Abbott Laboratories (Abbott Park, IL)   See Pricing
L-Cysteine   See Pricing Inhibitors of farnesyl protein transferase Merck & Co., Inc. (Rahway, NJ)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for L-Cysteine

Drugname Country Document Number Estimated Expiration Related US Patent
L-Cysteine Ireland 920715 2011-03-29   See Pricing
L-Cysteine Portugal 100314 2011-03-29   See Pricing
L-Cysteine World Intellectual Property Organization (WIPO) 9217476 2011-03-29   See Pricing
L-Cysteine Austria 155038 2008-09-13   See Pricing
L-Cysteine Austria 176400 2008-09-13   See Pricing
L-Cysteine Australia 4327089 2008-09-13   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Johnson and Johnson
Medtronic
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.